Lipoprotein-associated phospholipase A2 (Lp-PLA2) is a platelet activating factor acetylhydrolase, which is found to be involved in atherosclerosis as an established and independent risk biomarker of atherosclerosis-related CVD. The gene discussed is LCAT; the disease is atherosclerosis.